The impact of economic growth of pharmaceutical manufacturing industry on industrial agglomeration in the Yangtze River Delta region: an empirical analysis based on panel data 2008-2015CHEN Xiao-yu, WANG Jun-xia, XIA Yu-qi, ZHUANG Qian, CHU Shu-zhen241-245
Construction of a fast, efficient and high-quality new drug research and development system in medical colleges and universitiesHE Bing, YANG Shi-yan246-253
Galcanezumab: a new human monoclonal antibody for the prophylactic treatment of migraineLI Chun-xiao, CHEN Dan, MA Xiang-yu, LIU Jian-fang254-257
Analysis of the requirements for the pharmaceutical product lifecycle management refer to the ICH Q12 draftXU Li-hua, LIAN Xiao-yan, ZHANG Ling-chao, ZHANG Ning258-263
Common deficiencies of CMC dossiers for biologics marketing applications and key points to consider in review processZHOU Li-ting, LUO Jian-hui264-268
Establishment of morphine intravenous self-administration model at the fixed-ratio of 10 in ratsLI Bei-bei, ZHANG Huan, XIE Xing-zhou, QIU Yun-liang269-274
Research advances in dissolution mechanism and physical stability of solid dispersionsFU Ting-ting, ZUO Wen-bao, GUO Jue-shuo, YANG Jian-hong275-280
Advances in modern pharmaceutical action of Moutan Cortex in recent five yearsWU Chun-cao, GUO Xiao-hong, LIU Xia, YANG Min, WU Wen-hui281-284
Predictive analysis of quality markers: a case study of Scutellariae RadixHUANG Guang-qiang, LIANG Jie, LIN Jing, CHEN Xiao-si, XIN Chen-xi, YANG Chuan-chuan, ZHOU Yu-shan285-292
Bioequivalence study of two preparations of recombinant human parathyroid hormone (1-34) injection in healthy volunteersHU Chao, DONG Li-hou, WANG Ying, HAN Min, GOU Zhong-ping, ZHENG Li293-298